Considering that NF-κB phosphorylation occurs in various CNS cells that can be independently affected by AD-like pathology, the lack of significant change in bulk p-p65 levels due to the astrocyte-specific A20 intervention is plausible. This evidence concerns the gene TNFAIP3 and Alzheimer disease.